Home Search
healthcare data - search results
If you're not happy with the results, please do another search
New white paper will give Government more control over NHS
The legislative changes in the white paper released today (11 February) include giving local and central Government more control over the NHS - which is expected to be implemented in 2022.
Empowering governments and their people through digitisation
Tracey Lethbridge, head of UK public sector at OpenText, discusses how digital technologies could empower governments and their people during the current pandemic and beyond.
The challenge of diagnosing depression could be solved by machines
Machine learning could be the solution to the "big challenges" of accurately diagnosing depression, say scientists at the University of Birmingham.
AstraZeneca vaccine cannot stop the South African mutation
The new results led to the South African Government suspending use of AstraZeneca in their vaccination programme, as it is no longer able to stop the mutation - but could still prevent hospitalisation and fatality.
UK regulator assures safety of COVID-19 vaccines
Recent data published by the UK’s independent medicines regulator assures the Pfizer/BioNTech and the Oxford University/AstraZeneca vaccines meet strict regulatory standards for safety
Clinical trial looks into mixing different COVID-19 vaccines
A world-first clinical trial looking into mixing different COVID-19 vaccine doses has been backed by £7 million of government funding.
Climate change in South Africa could cost up to 20% of GDP
The impact of climate change in South Africa can be seen in economic productivity, healthcare outcomes and labour availability - but what could it cost the population in the future, if left unchecked?
ECMO machine reduces COVID-19 deaths by 45% for “sickest patients”
According to data collected by 400 healthcare professionals at the worst moment of the US outbreak, the life support machine that acts in place of the heart and lungs is crucial to reducing COVID-19 deaths for the critically ill.
Treating bovine tuberculosis (bTB) with artificial intelligence
Craig Rhodes, EMEA Industry Lead for Artificial Intelligence Healthcare and Life Science at NVIDIA, explores how bovine tuberculosis (bTB) can be monitored and treated more effectively and efficiently using Artificial Intelligence (AI).
Novavax vaccine is 85.6% efficient against UK COVID mutation
Phase Three data from the UK trial shows that Novavax still works powerfully against the UK mutation, with a less intense impact on the South African mutation at 60%.
UK hits melancholy milestone of over 100,000 COVID deaths
Prime Minister Boris Johnson announced that he had done "everything possible" to prevent 100,000 COVID deaths, as the UK witnesses 50,099 fatalities in the space of 79 days.
COVID-19 spike proteins could evolve against immune responses
A new study suggests that COVID-19 spike proteins could evolve to disguise themselves from the human immune system.
Scientists use immune system to predict likelihood of long COVID
Cambridge researchers have published their findings on how the immune system could be an early clue for the later development of severe or long COVID.
UK bans flights from Latin American countries over Brazilian mutation
The UK has banned Latin American countries and Portugal from travelling to the UK as of today (15 January), over increasing fears about the Brazilian COVID-19 mutations.
The vaccine isn’t a silver bullet for longstanding pressures in elderly care
Jitesh Patel, Project Director at Kajima Partnerships discusses why the vaccine is not a silver bullet for longstanding pressures in elderly care and how the sector must adapt post-pandemic.
76% of COVID-19 patients still have one symptom, after six months
While long COVID is slowly becoming more understood, ordinary COVID-19 patients are experiencing lasting effects - scientists discovered that 76% of people have atleast one recurring symptom, six months after the original illness.
New framework to improve diagnosis and treatment of rare diseases
The new UK Rare Diseases Framework sets out to accelerate diagnosis and improve the treatment of rare diseases.
On the fast-track to reimbursement: Germany unlocks business opportunities for digital health innovators
Prof. Dr. Freimut Schliess discusses digital health innovation in Germany, tackling larger public health challenges being faced.
Flu vaccine sees highest uptake on record
Over 80% of those aged 65+ in England have received the flu vaccine so far this year – the highest uptake on record.
Key trends for the public sector in 2021
Peter Ford, Public Sector Industry Principal at Pegasystems, explores some of the top trends for the public sector in 2021 which include chatbots, intelligent automation and citizen data scientists.